#Breaking: Sales of Johnson & Johnson’s Covid-19 vaccine hit $100m in the first three months of the year

Sales of Johnson & Johnson’s Covid-19 vaccine hit $100m in the first three months of the year as the company awaits findings from regulators on whether it can resume the rollout of its jab https://t.co/itZGGmPQtq

— Financial Times (@FinancialTimes) April 20, 2021

Source: Twitter